HEADER VIRAL PROTEIN/IMMUNE SYSTEM 09-NOV-15 5EN2 TITLE MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD TITLE 2 HEMORRHAGIC FEVER MAMMARENAVIRUSES COMPND MOL_ID: 1; COMPND 2 MOLECULE: GD01 HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: GD01 LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: PRE-GLYCOPROTEIN POLYPROTEIN GP COMPLEX; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: JUNIN MAMMARENAVIRUS; SOURCE 13 ORGANISM_COMMON: JUNV; SOURCE 14 ORGANISM_TAXID: 11619; SOURCE 15 GENE: GPC, GP-C; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS IMMUNOGLOBULIN, GLYCOPROTEIN, VIRUS, COMPLEX, VIRAL PROTEIN-IMMUNE KEYWDS 2 SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.MAHMUTOVIC,L.CLARK,S.LEVIS,A.BRIGGILER,D.ENRIA,S.C.HARRISON, AUTHOR 2 J.ABRAHAM REVDAT 5 27-SEP-23 5EN2 1 HETSYN LINK REVDAT 4 29-JUL-20 5EN2 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 11-DEC-19 5EN2 1 REMARK REVDAT 2 13-SEP-17 5EN2 1 REMARK REVDAT 1 30-DEC-15 5EN2 0 JRNL AUTH S.MAHMUTOVIC,L.CLARK,S.C.LEVIS,A.M.BRIGGILER,D.A.ENRIA, JRNL AUTH 2 S.C.HARRISON,J.ABRAHAM JRNL TITL MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW JRNL TITL 2 WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES. JRNL REF CELL HOST MICROBE V. 18 705 2015 JRNL REFN ESSN 1934-6069 JRNL PMID 26651946 JRNL DOI 10.1016/J.CHOM.2015.11.005 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 63032 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 3168 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.33 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4498 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2406 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4269 REMARK 3 BIN R VALUE (WORKING SET) : 0.2388 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.09 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 229 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4459 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 125 REMARK 3 SOLVENT ATOMS : 886 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.08970 REMARK 3 B22 (A**2) : -0.42000 REMARK 3 B33 (A**2) : -1.66970 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.218 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.138 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.130 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.120 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.120 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4718 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6433 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1601 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 99 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 672 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4718 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 656 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5905 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.86 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EN2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215113. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97890 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63113 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.821 REMARK 200 RESOLUTION RANGE LOW (A) : 68.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.22600 REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 1.41800 REMARK 200 R SYM FOR SHELL (I) : 1.41800 REMARK 200 FOR SHELL : 0.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.5 REMARK 200 STARTING MODEL: 3KAS, 3FMG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: JUNV GP1 AND GD01 FAB, WHEN MIXED IN REMARK 280 EQUIMOLAR RATIO CRYSTALLIZED IN MOTHER LIQUOR CONTAINING 24% PEG REMARK 280 3350 (V/V), 10 MM TRIS, PH 8.0, 150 MM NACL., VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.05500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.82000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.39500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.82000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.05500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.39500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 128 REMARK 465 GLY A 129 REMARK 465 ASP A 130 REMARK 465 THR A 131 REMARK 465 THR A 132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 88 -178.72 -172.88 REMARK 500 TYR A 99 76.11 -152.44 REMARK 500 ASN A 100B 42.88 -104.45 REMARK 500 ASP A 173 -3.12 74.14 REMARK 500 GLN B 8 131.52 -19.45 REMARK 500 ALA B 51 -34.20 63.76 REMARK 500 ALA B 84 -179.72 -175.14 REMARK 500 ASN B 190 -67.37 -106.24 REMARK 500 SER C 97 -21.90 -155.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 650 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH A 651 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH A 652 DISTANCE = 6.94 ANGSTROMS REMARK 525 HOH A 653 DISTANCE = 7.08 ANGSTROMS REMARK 525 HOH A 654 DISTANCE = 7.49 ANGSTROMS REMARK 525 HOH A 655 DISTANCE = 7.99 ANGSTROMS REMARK 525 HOH A 656 DISTANCE = 8.36 ANGSTROMS REMARK 525 HOH B 734 DISTANCE = 6.55 ANGSTROMS REMARK 525 HOH B 735 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH B 736 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH B 737 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH B 738 DISTANCE = 7.33 ANGSTROMS REMARK 525 HOH B 739 DISTANCE = 8.25 ANGSTROMS REMARK 525 HOH B 740 DISTANCE = 8.46 ANGSTROMS REMARK 525 HOH B 741 DISTANCE = 8.62 ANGSTROMS REMARK 525 HOH C 886 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH C 887 DISTANCE = 6.50 ANGSTROMS REMARK 525 HOH C 888 DISTANCE = 6.93 ANGSTROMS REMARK 525 HOH C 889 DISTANCE = 6.94 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN D 6 DBREF 5EN2 A 1 213 PDB 5EN2 5EN2 1 213 DBREF 5EN2 B 1 212 PDB 5EN2 5EN2 1 212 DBREF 5EN2 C 87 227 UNP P26313 GLYC_JUNIN 87 227 SEQRES 1 A 224 GLU VAL LYS LEU GLN GLN SER GLY ALA GLU LEU ALA ARG SEQRES 2 A 224 PRO GLY THR SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 A 224 TYR THR PHE THR ASN TYR TRP MET GLN TRP ILE LYS GLN SEQRES 4 A 224 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY ALA VAL TYR SEQRES 5 A 224 PRO GLY ASP GLY ASP THR ARG PHE SER GLN LYS PHE LYS SEQRES 6 A 224 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 A 224 ALA TYR MET GLN LEU SER SER LEU SER SER GLU ASP SER SEQRES 8 A 224 ALA VAL TYR PHE CYS ALA ARG ARG ARG VAL TYR TYR GLY SEQRES 9 A 224 SER ASN TYR ILE TYR ALA LEU ASP TYR TRP GLY GLN GLY SEQRES 10 A 224 THR SER VAL THR VAL SER ALA ALA LYS THR THR ALA PRO SEQRES 11 A 224 SER VAL TYR PRO LEU ALA PRO VAL CYS GLY ASP THR THR SEQRES 12 A 224 GLY SER SER VAL THR LEU GLY CYS LEU VAL LYS GLY TYR SEQRES 13 A 224 PHE PRO GLU PRO VAL THR LEU THR TRP ASN SER GLY SER SEQRES 14 A 224 LEU SER SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SEQRES 15 A 224 SER ASP LEU TYR THR LEU SER SER SER VAL THR VAL THR SEQRES 16 A 224 SER SER THR TRP PRO SER GLN SER ILE THR CYS ASN VAL SEQRES 17 A 224 ALA HIS PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE SEQRES 18 A 224 GLU PRO ARG SEQRES 1 B 212 ASP ILE VAL MET THR GLN SER GLN LYS PHE MET SER THR SEQRES 2 B 212 SER ILE GLY ASP ARG VAL SER ILE THR CYS LYS ALA SER SEQRES 3 B 212 GLN ASN VAL GLY SER ALA VAL ALA TRP TYR GLN GLN LYS SEQRES 4 B 212 PRO GLY GLN SER PRO LYS LEU LEU ILE TYR SER ALA SER SEQRES 5 B 212 ASN ARG TYR THR GLY VAL PRO ASP ARG PHE ILE GLY SER SEQRES 6 B 212 GLU SER GLY THR ASP PHE THR LEU THR ILE SER ASN MET SEQRES 7 B 212 GLN SER GLU ASP LEU ALA ASP TYR PHE CYS GLN GLN TYR SEQRES 8 B 212 SER SER TYR PRO LEU ALA PHE GLY ALA GLY THR LYS LEU SEQRES 9 B 212 GLU LEU LYS ARG ALA ASP ALA ALA PRO THR VAL SER ILE SEQRES 10 B 212 PHE PRO PRO SER SER GLU GLN LEU THR SER GLY GLY ALA SEQRES 11 B 212 SER VAL VAL CYS PHE LEU ASN ASN PHE TYR PRO LYS ASP SEQRES 12 B 212 ILE ASN VAL LYS TRP LYS ILE ASP GLY SER GLU ARG GLN SEQRES 13 B 212 ASN GLY VAL LEU ASN SER TRP THR ASP GLN ASP SER LYS SEQRES 14 B 212 ASP SER THR TYR SER MET SER SER THR LEU THR LEU THR SEQRES 15 B 212 LYS ASP GLU TYR GLU ARG HIS ASN SER TYR THR CYS GLU SEQRES 16 B 212 ALA THR HIS LYS THR SER THR SER PRO ILE VAL LYS SER SEQRES 17 B 212 PHE ASN ARG ASN SEQRES 1 C 141 ASP LEU PRO LEU LEU CYS THR LEU ASN LYS SER HIS LEU SEQRES 2 C 141 TYR ILE LYS GLY GLY ASN ALA SER PHE LYS ILE SER PHE SEQRES 3 C 141 ASP ASP ILE ALA VAL LEU LEU PRO GLU TYR ASP VAL ILE SEQRES 4 C 141 ILE GLN HIS PRO ALA ASP MET SER TRP CYS SER LYS SER SEQRES 5 C 141 ASP ASP GLN ILE TRP LEU SER GLN TRP PHE MET ASN ALA SEQRES 6 C 141 VAL GLY HIS ASP TRP TYR LEU ASP PRO PRO PHE LEU CYS SEQRES 7 C 141 ARG ASN ARG THR LYS THR GLU GLY PHE ILE PHE GLN VAL SEQRES 8 C 141 ASN THR SER LYS THR GLY ILE ASN GLU ASN TYR ALA LYS SEQRES 9 C 141 LYS PHE LYS THR GLY MET HIS HIS LEU TYR ARG GLU TYR SEQRES 10 C 141 PRO ASP SER CYS LEU ASP GLY LYS LEU CYS LEU MET LYS SEQRES 11 C 141 ALA GLN PRO THR SER TRP PRO LEU GLN CYS PRO HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET MAN D 5 11 HET MAN D 6 10 HET MAN D 7 11 HET NAG E 1 14 HET NAG E 2 14 HET CL B 301 1 HET NAG C 610 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 4 NAG 5(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 MAN 4(C6 H12 O6) FORMUL 6 CL CL 1- FORMUL 8 HOH *886(H2 O) HELIX 1 AA1 THR A 28 THR A 30 5 3 HELIX 2 AA2 GLN A 61 LYS A 64 5 4 HELIX 3 AA3 SER A 83 SER A 87 5 5 HELIX 4 AA4 SER A 156 SER A 158 5 3 HELIX 5 AA5 PRO A 200 SER A 203 5 4 HELIX 6 AA6 GLN B 79 LEU B 83 5 5 HELIX 7 AA7 SER B 121 SER B 127 1 7 HELIX 8 AA8 LYS B 183 GLU B 187 1 5 HELIX 9 AA9 HIS C 128 SER C 136 5 9 HELIX 10 AB1 SER C 138 VAL C 152 1 15 HELIX 11 AB2 THR C 182 ILE C 184 5 3 HELIX 12 AB3 ASN C 185 TYR C 200 1 16 SHEET 1 AA1 4 LYS A 3 GLN A 6 0 SHEET 2 AA1 4 VAL A 18 SER A 25 -1 O LYS A 23 N GLN A 5 SHEET 3 AA1 4 THR A 77 LEU A 82 -1 O MET A 80 N LEU A 20 SHEET 4 AA1 4 ALA A 67 ASP A 72 -1 N ASP A 72 O THR A 77 SHEET 1 AA2 6 GLU A 10 ALA A 12 0 SHEET 2 AA2 6 THR A 107 VAL A 111 1 O SER A 108 N GLU A 10 SHEET 3 AA2 6 ALA A 88 ARG A 96 -1 N TYR A 90 O THR A 107 SHEET 4 AA2 6 TYR A 32 GLN A 39 -1 N GLN A 35 O ALA A 93 SHEET 5 AA2 6 LEU A 45 VAL A 51 -1 O GLU A 46 N LYS A 38 SHEET 6 AA2 6 THR A 57 PHE A 59 -1 O ARG A 58 N ALA A 50 SHEET 1 AA3 4 SER A 120 LEU A 124 0 SHEET 2 AA3 4 SER A 135 TYR A 145 -1 O LEU A 141 N TYR A 122 SHEET 3 AA3 4 LEU A 174 THR A 184 -1 O LEU A 177 N VAL A 142 SHEET 4 AA3 4 VAL A 163 THR A 165 -1 N HIS A 164 O SER A 180 SHEET 1 AA4 4 SER A 120 LEU A 124 0 SHEET 2 AA4 4 SER A 135 TYR A 145 -1 O LEU A 141 N TYR A 122 SHEET 3 AA4 4 LEU A 174 THR A 184 -1 O LEU A 177 N VAL A 142 SHEET 4 AA4 4 VAL A 169 GLN A 171 -1 N GLN A 171 O LEU A 174 SHEET 1 AA5 3 THR A 151 TRP A 154 0 SHEET 2 AA5 3 THR A 194 HIS A 199 -1 O ASN A 196 N THR A 153 SHEET 3 AA5 3 THR A 204 LYS A 209 -1 O VAL A 206 N VAL A 197 SHEET 1 AA6 4 MET B 4 GLN B 6 0 SHEET 2 AA6 4 VAL B 19 ALA B 25 -1 O LYS B 24 N THR B 5 SHEET 3 AA6 4 ASP B 70 ILE B 75 -1 O PHE B 71 N CYS B 23 SHEET 4 AA6 4 PHE B 62 SER B 67 -1 N ILE B 63 O THR B 74 SHEET 1 AA7 6 PHE B 10 THR B 13 0 SHEET 2 AA7 6 THR B 102 LEU B 106 1 O GLU B 105 N MET B 11 SHEET 3 AA7 6 ASP B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA7 6 VAL B 33 GLN B 38 -1 N TYR B 36 O PHE B 87 SHEET 5 AA7 6 LYS B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA7 6 ASN B 53 ARG B 54 -1 O ASN B 53 N TYR B 49 SHEET 1 AA8 4 PHE B 10 THR B 13 0 SHEET 2 AA8 4 THR B 102 LEU B 106 1 O GLU B 105 N MET B 11 SHEET 3 AA8 4 ASP B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA8 4 ALA B 97 PHE B 98 -1 O ALA B 97 N GLN B 90 SHEET 1 AA9 4 THR B 114 PHE B 118 0 SHEET 2 AA9 4 GLY B 129 PHE B 139 -1 O ASN B 137 N THR B 114 SHEET 3 AA9 4 TYR B 173 THR B 182 -1 O LEU B 181 N ALA B 130 SHEET 4 AA9 4 VAL B 159 TRP B 163 -1 N LEU B 160 O THR B 178 SHEET 1 AB1 4 SER B 153 ARG B 155 0 SHEET 2 AB1 4 ASN B 145 ILE B 150 -1 N ILE B 150 O SER B 153 SHEET 3 AB1 4 SER B 191 THR B 197 -1 O THR B 197 N ASN B 145 SHEET 4 AB1 4 ILE B 205 ASN B 210 -1 O ILE B 205 N ALA B 196 SHEET 1 AB2 7 LEU C 90 LEU C 94 0 SHEET 2 AB2 7 HIS C 98 GLY C 103 -1 O HIS C 98 N LEU C 94 SHEET 3 AB2 7 ALA C 106 ASP C 113 -1 O PHE C 108 N ILE C 101 SHEET 4 AB2 7 LEU C 214 PRO C 219 -1 O LEU C 214 N ASP C 113 SHEET 5 AB2 7 PHE C 175 ASN C 178 -1 N VAL C 177 O MET C 215 SHEET 6 AB2 7 PHE C 162 CYS C 164 -1 N LEU C 163 O GLN C 176 SHEET 7 AB2 7 VAL C 124 ILE C 126 -1 N ILE C 126 O PHE C 162 SSBOND 1 CYS A 22 CYS A 92 1555 1555 2.05 SSBOND 2 CYS A 140 CYS A 195 1555 1555 2.04 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.07 SSBOND 4 CYS B 134 CYS B 194 1555 1555 2.07 SSBOND 5 CYS C 92 CYS C 226 1555 1555 2.04 SSBOND 6 CYS C 135 CYS C 164 1555 1555 2.02 SSBOND 7 CYS C 207 CYS C 213 1555 1555 2.11 LINK ND2 ASN C 105 C1 NAG C 610 1555 1555 1.44 LINK ND2 ASN C 166 C1 NAG E 1 1555 1555 1.43 LINK ND2 ASN C 178 C1 NAG D 1 1555 1555 1.43 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.42 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.40 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.40 LINK O3 BMA D 3 C1 MAN D 7 1555 1555 1.44 LINK O3 MAN D 4 C1 MAN D 5 1555 1555 1.44 LINK O6 MAN D 4 C1 MAN D 6 1555 1555 1.40 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 CISPEP 1 PHE A 146 PRO A 147 0 -2.95 CISPEP 2 GLU A 148 PRO A 149 0 1.46 CISPEP 3 TRP A 188 PRO A 189 0 2.07 CISPEP 4 TYR B 94 PRO B 95 0 3.45 CISPEP 5 TYR B 140 PRO B 141 0 1.96 CRYST1 52.110 74.790 177.640 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019190 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013371 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005629 0.00000